75,000-share Form 144 filing by LifeStance Health (NASDAQ: LFST)
Rhea-AI Filing Summary
LifeStance Health (LFST) filed a Form 144 reporting proposed sales of 75,000 shares of Common Stock, with an aggregate value listed as $641,580.00, dated 05/07/2026.
The filing also records recent dispositions: 5,101 shares on 04/21/2026 for $35,749.48, 7,752 shares on 04/23/2026 for $54,267.10, and 62,147 shares on 04/24/2026 for $438,074.20. The excerpt shows two prior private placement transfers dated 06/01/2017 of 37,500 shares each to Vitthal LLC and Shama LLC.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed sales totaling 75,000 shares and records recent open-market dispositions in April 2026.
The filing is a regulatory notice required when an affiliate or selling security holder intends to sell restricted or control securities. It lists the proposed aggregate amount 75,000 shares and an aggregate value of $641,580.00 dated 05/07/2026.
Recent completed dispositions are shown with exact counts and proceeds on 04/21/2026, 04/23/2026, and 04/24/2026. The filing references prior private placement transfers dated 06/01/2017. Cash‑flow treatment and whether sales are subject to any lock‑up or transfer restrictions are not stated in the excerpt.